Nalaganje...

EXTH-19. COMBINATION OF IN VITRO TUMOR TREATING FIELDS AND TEMOZOLOMIDE DECREASE PROLIFERATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES

BACKGROUND: Tumor treating fields (TTFields) are FDA-approved for treatment of newly-diagnosed and recurrent glioblastoma. Adding TTFields therapy to standard-of-care temozolomide (TMZ) extended progression-free survival and overall survival in newly-diagnosed glioblastoma patients. In this study, c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Michelhaugh, Sharon K, Kiousis, Sam, Mittal, Sandeep
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692458/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.314
Oznake: Označite
Brez oznak, prvi označite!